|
[Related PubMed/MEDLINE]
Total Number of Papers: 158
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: CMZ |
| Long Form |
: cefmetazole |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-beta-lactamase-producing Enterobacteriaceae. |
ERT, MEM, MICs, NDM |
| 2 |
2019 |
Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae. |
CRE, IMP, MEM, MICs |
| 3 |
2019 |
Change in the Antimicrobial Resistance Profile of Extended-Spectrum beta-Lactamase-Producing Escherichia coli. |
AMK, CPFX, ESBL-EC, FMOX, GM, IPM, LVFX, MEPM, MINO, non-ESBL-EC |
| 4 |
2019 |
In Vitro Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing Enterobacteriaceae. |
CFU, CPE, ERT, MEM |
| 5 |
2019 |
Induction of plasmid-mediated AmpC beta-lactamase DHA-1 by piperacillin/tazobactam and other beta-lactams in Enterobacteriaceae. |
PIP/TZB |
| 6 |
2018 |
[Drug-induced immune hemolytic anemia caused by cefmetazole]. |
DIIHA, Hb |
| 7 |
2017 |
Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy. |
CBP, ESBL-PE, non-CBPBL, PT, UTIs |
| 8 |
2017 |
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital. |
CRP, E. coli, ESBL, SOFA, TAZ/PIPC |
| 9 |
2017 |
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli. |
E. coli, ESBL, FMOX, FOM, IPM/CS, UTI |
| 10 |
2017 |
Optimal dosage of cefmetazole for intraoperative antimicrobial prophylaxis in patients undergoing surgery for colorectal cancer. |
PK/PD |
| 11 |
2013 |
[Antimicrobial activity of several drugs against extended-spectrum beta-lactamase positive Enterobacteriaceae isolates in Gifu and Aichi prefecture]. |
DRPM, ESBL, IPM, MEPM, TAZ/PIPC |
| 12 |
2012 |
Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion. |
CEZ, CTM, FMOX, PAA, TAZ/PIPC |
| 13 |
2007 |
Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. |
AST |
| 14 |
2007 |
Effects of air tourniquet on the antibiotics concentration, in bone marrow, injected just before the start of operation. |
MIC, THA, TKA |
| 15 |
2007 |
Humanization of excretory pathway in chimeric mice with humanized liver. |
SCID, uPA |
| 16 |
2007 |
[Fundamental study on the selection of antimicrobial prophylactic agents in abdominal surgery]. |
CEZ, CTM |
| 17 |
2006 |
Determination of cefmetazole residue at pharmaceutical manufacturing facilities by chemiluminescence flow injection analysis. |
FIA |
| 18 |
2006 |
LC/MS/MS method for the determination of trace amounts of cefmetazole and cefpodoxime proxetil contaminants in pharmaceutical manufacturing environments. |
CPDX-PR |
| 19 |
2006 |
Verification of cefmetazole and cefpodoxime proxetil contamination to other pharmaceuticals by liquid chromatography-tandem mass spectrometry. |
CPDX-PR, OLM |
| 20 |
2006 |
[Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery]. |
FMOX, FOM |
| 21 |
2004 |
Influence of various antimicrobial agents on the intestinal flora in an intestinal MRSA-carrying rat model. |
CEZ, FMOX, MRSA, PIPC |
| 22 |
2003 |
Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. |
ABK, CTM, FMOX, FOM, IPM, MINO, MRSA, OFLX, PAPM, SBT/CPZ, VCM |
| 23 |
2003 |
[Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci]. |
CEZ, CTM, FOM, MSCNS, MSSA, PIPC |
| 24 |
2003 |
[Successful combination therapy of teicoplanin with cefmetazole on postoperative cardiovascular MRSA infections: clinical report on two cases]. |
MRSA, TEIC |
| 25 |
2003 |
[Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002]. |
CEZ, CTM, FMOX, SBT/CPZ |
| 26 |
2001 |
[A questionnaire survey on the theory of postoperative infection prophylaxis in gynecology]. |
AMP, CEZ, CTM, FMOX |
| 27 |
2001 |
[Immunological properties of S-1090, cefmatilen hydrochloride hydrate]. |
ASA, CET, CTM, ELISA, PCA, PCG |
| 28 |
2000 |
[Combination effect of teicoplanin and beta-lactams on MRSA]. |
CFPM, FMOX, PAPM |
| 29 |
1999 |
Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection. |
CEZ, CPZ, CTM, FMOX, G-CSF, HGF, LMOX, PBP3, TNF-alpha |
| 30 |
1999 |
[A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-negative bacilli]. |
AMK, FOM, GM, LMOX, MINO, ST |
| 31 |
1998 |
Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. |
AW-GC, HA, ISP |
| 32 |
1998 |
[A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci]. |
CCL, LMOX, MINO, OFLX, ST, VCM |
| 33 |
1998 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. |
ABK, AMK, CAM, CCL, CEZ, CFIX, CPFX, CPR, CPZ, CRMN, CTM, CZOP, FMOX, GM, IPM, LMOX, MINO, OFLX, TFLX, UTIs, VCM |
| 34 |
1997 |
Inhibitory effects of antibiotics on platelet aggregation in vitro. |
ADP, AZT, CMD, CTM, FMOX, LMOX |
| 35 |
1997 |
[Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract]. |
CTM, CXM, ISP |
| 36 |
1996 |
[The evaluation of cefmetazole in clinical use. The study group of cefmetazole in clinical use]. |
--- |
| 37 |
1996 |
[The taxonomic distribution, characteristic and susceptibility against antimicrobial agents of methicillin-resistant staphylococci isolated from blood]. |
CCL, CET, FMOX, FOM, MRCNS, MRSA |
| 38 |
1995 |
[Lytic action of cefminox against slowly growing bacteria]. |
CMNX, E. coli |
| 39 |
1994 |
[Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin]. |
ASA, CET, PCA, PCG, PHA, PIPC, TAZ, TAZ/PIPC |
| 40 |
1994 |
[Efficacy of combination therapy against MRSA in Ibaraki Prefecture]. |
ABK, CAZ, FMOX, FOM, MRSA, PIPC |
| 41 |
1994 |
[Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics]. |
CAZ, CZON, CZOP, FMOX, MRSA |
| 42 |
1993 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward]. |
ABK, FOM, IPM, MIC, MRSA, VCM |
| 43 |
1993 |
[Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs]. |
CEZ, MRSA, MSSA |
| 44 |
1993 |
[Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs]. |
CTM, MRSA, MSSA |
| 45 |
1992 |
Comparisons of the bacterial flora in genital regions at non-pregnancy. |
--- |
| 46 |
1992 |
Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazole. |
--- |
| 47 |
1992 |
Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition. |
subMICs |
| 48 |
1992 |
[A case of staphylococcal enterocolitis caused by methicillin resistant Staphylococcus aureus]. |
MRSA, TSST-I |
| 49 |
1992 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef]. |
ABK, FMOX, MRSA |
| 50 |
1992 |
[Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method]. |
CEZ, FMOX |
| 51 |
1992 |
[In vitro study on efficacy of combination use of aspoxicillin and beta-lactam preparations (ceftazidime, cefmetazole and aztreonam) against bacteria isolated from abdominal infections]. |
ASPC, AZT, CAZ |
| 52 |
1990 |
[A study of tissue transfer of cefmetazole in the blood and uterus in pregnant rabbits]. |
--- |
| 53 |
1990 |
[Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study]. |
AMK, AZT, PIPC |
| 54 |
1990 |
[Comparative study of the bacterial flora in both uterocervical and uterine regions]. |
--- |
| 55 |
1990 |
[Hospital and district differences in susceptibilities to antibiotics of main clinical isolates]. |
CEZ, GM |
| 56 |
1990 |
[In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics]. |
CTM, CTT, CZX, GM, LMOX, NTL |
| 57 |
1990 |
[Long-term surviving child with acute lymphoblastic leukemia complicated with legionellosis]. |
ALL, EM, LCM, MINO |
| 58 |
1990 |
[Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities]. |
CEZ, GM |
| 59 |
1990 |
[Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders]. |
NTL |
| 60 |
1989 |
Differential effects of cefmetazole sodium on the reproductive system of infant and pubertal male rats. |
NMTT |
| 61 |
1989 |
[A successful treatment of an infective endocarditis caused by methicillin-resistant Staphylococcus aureus with a combination of cefmetazole with fosfomycin]. |
FOM, MRSA |
| 62 |
1989 |
[Antibiotics-induced agranulocytosis. Patient's IgG inhibits a GM colony formation]. |
--- |
| 63 |
1989 |
[Clinical experience of chemotherapy with cefmetazole for severe infections accompanying malignant hematological disorders]. |
--- |
| 64 |
1989 |
[Detection of inducible beta-lactamase in sputum--clinical studies on Pseudomonas respiratory infection]. |
PIPC |
| 65 |
1989 |
[Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli]. |
CEZ, CFX, CTT, LMOX |
| 66 |
1989 |
[Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics]. |
CEZ, PIPC |
| 67 |
1989 |
[Urinary tract infection associated with urinary calculi. 2. Effects of antibiotics on bacteria within infected stones]. |
--- |
| 68 |
1988 |
[A nationwide study of the antimicrobial susceptibility of clinical isolates of Staphylococcus aureus in Japan]. |
CEZ, GM |
| 69 |
1988 |
[Antibacterial activity of human cervical mucus]. |
--- |
| 70 |
1988 |
[Clinical study of postoperative infection of gastrointestinal cancer. Randomized study of preventive efficacy of cefmetazole versus cephalothin in postoperative infection of gastric and colorectal cancer]. |
--- |
| 71 |
1988 |
[In vitro susceptibilities of clinical isolates of Staphylococcus aureus]. |
CEZ, CMX, FOM, LMOX, MINO, NFLX |
| 72 |
1988 |
[Nephrotoxicity of cefodizime sodium in rats--single and 14-day repeated intravenous administration]. |
CER, CEZ |
| 73 |
1988 |
[Penetration of cefmetazole and netilmicin into the cerebrospinal fluid]. |
CSF, NTL |
| 74 |
1987 |
[Antibacterial activities of various aminoglycosides against clinically isolated methicillin-resistant Staphylococcus aureus]. |
AGs, AMK, CEZ, DKB, GM, MRSA, NTL, SISO, TOB |
| 75 |
1987 |
[Clinical evaluation of cefuzonam in pediatrics and a study on the penetration into cerebrospinal fluid]. |
CEZ, CMX, CPZ, CTM |
| 76 |
1987 |
[Clinical study on effects of cefmetazole on severe infections accompanied by hematologic diseases]. |
--- |
| 77 |
1987 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution]. |
AZT, CCL, CEZ, CFX, CMX, CPZ, CRMN, CTM, CTX, CZX, LMOX, NA, OFLX, PPA, ST |
| 78 |
1987 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility]. |
AZT, CCL, CEX, CEZ, CFX, CMX, CPZ, CRMN, CTM, CTX, CZX, LMOX, OFLX |
| 79 |
1987 |
[Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol]. |
CPZ, LMOX |
| 80 |
1987 |
[Fundamental and clinical studies on cefuzonam in the field of pediatrics]. |
CEZ, CMX, CPZ, CTM, LMOX |
| 81 |
1987 |
[Fundamental and clinical studies on cefuzoname in the pediatric field]. |
CEZ, CMD, CMX, CSF, CZON, LMOX |
| 82 |
1987 |
[Laboratory and clinical studies of flomoxef]. |
CEZ, LMOX |
| 83 |
1987 |
[Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan]. |
CEZ, GM |
| 84 |
1987 |
[Pharmacokinetics of cefmetazole during and after surgical operations]. |
AUCs, HPLC |
| 85 |
1987 |
[Susceptibility of clinical isolates to aztreonam]. |
AZT, CFS, CPZ, CTX, LMOX |
| 86 |
1986 |
[A nationwide study of the antimicrobial susceptibility of clinical isolates of Escherichia coli in Japan]. |
CEZ, GM |
| 87 |
1986 |
[A nationwide study of the antimicrobial susceptibility of clinical isolates of Klebsiella sp. in Japan]. |
CEZ, GM |
| 88 |
1986 |
[A study on the disulfiram-like reaction of T-2588. Influence of the consecutive administration of T-2588 on hepatic alcohol dehydrogenase and aldehyde dehydrogenase activities and blood levels of ethanol and acetaldehyde]. |
CEX |
| 89 |
1986 |
[Antibiotic susceptibility of bacteria isolated from surgical infections (first report)]. |
AMK, CET, CEZ, CMX, CPZ, CTM, CTX, CZX, GM, LCM, LMOX, PIPC |
| 90 |
1986 |
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution]. |
CCL, CMX, CPZ, CTM, CTX, CZX, LMOX, PPA |
| 91 |
1986 |
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility]. |
CCL, CEX, CEZ, CMX, CTM, CZX, LMOX, UTI |
| 92 |
1986 |
[Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985]. |
CET, CEX, CEZ, CFS, CFX, CMX, CPZ, CTM, CTX, CZX, LMOX |
| 93 |
1986 |
[Effect of cefminox on bacterial flora in human adult feces]. |
CMNX, CTX |
| 94 |
1986 |
[Fundamental and clinical studies on imipenem/cilastatin sodium in the pediatric field]. |
CAZ, CEZ, CFS, CMD, CPZ, CZX, LMOX, PIPC |
| 95 |
1986 |
[In vitro susceptibility of bacterial isolates from patients with respiratory tract infections to beta-lactam antibiotics]. |
CEZ, CMX, CTM |
| 96 |
1986 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes]. |
CPBZ, CPZ, CTT, LMOX |
| 97 |
1986 |
[Transference of antibiotics into prostatic tissues: sampling method by transurethral resection for the measurement of the concentration of antibiotics in prostatic tissue]. |
FOM, TURP |
| 98 |
1985 |
Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus. |
PBP |
| 99 |
1985 |
Cefmetazole: clinical evaluation of efficacy and safety in Japan. |
CPZ, LMOX, Me-TZ |
| 100 |
1985 |
Improvement of bioavailability of poorly absorbed drugs. V. Effect of surfactants on the promoting effect of medium chain glyceride for the rectal absorption of beta-lactam antibiotics in rats and dogs. |
MCG |
|
A Search Service for Abbreviation / Long Form
